Evidence map›Paper›PMID 34703820›Full record

ArticleJournal of cancer prevention2021

F-box Protein βTrCP1 Is a Substrate of Extracellular Signal-regulated Kinase 2.

Cheol-Jung Lee, Ga-Eun Lee, Hyun-Jung An, Eun Suh Cho, Weidong Chen, Joo Young Lee, Han Chang Kang, Hye Suk Lee, Yong-Yeon Cho

Open access · diamondAbstract read
In one paragraph

Article in Journal of cancer prevention, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Cheol-Jung LeeBRL & BK21-4th Team, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.ORCID https://orcid.org/0000-0002-0322-2018
Ga-Eun LeeBRL & BK21-4th Team, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.ORCID https://orcid.org/0000-0001-8700-209X
Hyun-Jung AnBRL & BK21-4th Team, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.ORCID https://orcid.org/0000-0002-3189-7944
Eun Suh ChoDepartment of Biochemistry, College of Biological Sciences, University of Minnesota, Minneapolis, MN, USA.ORCID https://orcid.org/0000-0001-5373-2916
Weidong ChenBRL & BK21-4th Team, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.ORCID https://orcid.org/0000-0002-4015-6005
Joo Young LeeBRL & BK21-4th Team, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.ORCID https://orcid.org/0000-0002-6020-3040
Han Chang KangBRL & BK21-4th Team, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.ORCID https://orcid.org/0000-0003-0696-1155
Hye Suk LeeBRL & BK21-4th Team, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.ORCID https://orcid.org/0000-0003-1055-9628
Yong-Yeon ChoBRL & BK21-4th Team, College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.ORCID https://orcid.org/0000-0003-1107-2651
The Catholic University of Korea Bucheon St. Mary's Hospital · KRUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

F-box proteins, consisting of 69 members which are organized into the three subclasses FBXW, FBXL, and FBXO, are the substrate specific recognition subunits of the SKP1-Cullin 1-F-box protein E3 ligase complex. Although βTrCP 1 and 2, members of the FBXW subfamily, are known to regulate some protein stability, molecular mechanisms by which these proteins can recognize proper substrates are unknown. In this study, it was found that βTrCP1 showed strong interaction with members of mitogen-activated protein kinases. Although extracellular signal-regulated kinase (ERK) 3, p38β, and p38δ showed weak interactions, ERK2 specifically interacted with βTrCP1 as assessed by immunoprecipitation. In interaction domain determination experiments, we found that ERK2 interacted with two independent ERK docking sites located in the F-box domain and linker domain, but not the WD40 domain, of βTrCP1. Notably, mutations of βTrCP1 at the ERK docking sites abolished the interaction with ERK2. βTrCP1 underwent phosphorylation by EGF stimulation, while the presence of the mitogen-activated protein kinase kinases inhibitor U0126, genetic silencing by sh-ERK2, and mutation of the ERK docking site of βTrCP1 inhibited phosphorylation. This inhibition of βTrCP1 phosphorylation resulted in a shortened half-life and low protein levels. These results suggest that ERK2-mediated βTrCP1 phosphorylation may induce the destabilization of βTrCP1.

Indexed as

Beta transducin repeat-containing proteinBinding siteERK pathwayPhosphorylationProtein interaction domains

Identifiers

PMID34703820
PMCPMC8511579
OpenAlexW3206626528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.